Dr Katrina Farrell

  • Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)

email: Katrina.Farrell@glasgow.ac.uk

Department of Haematology, Forth Valley Royal Hospital, Stirling Road, Larbert, FK5 4WR

Import to contacts

Publications

List by: Type | Date

Jump to: 2018 | 2016 | 2013 | 2012 | 2011
Number of items: 7.

2018

Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)

2016

Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)

2013

Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)

2012

Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)

2011

Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)

Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)

Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)

This list was generated on Fri Apr 12 22:39:33 2024 BST.
Jump to: Articles
Number of items: 7.

Articles

Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)

Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)

Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)

Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)

Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)

Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)

Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)

This list was generated on Fri Apr 12 22:39:33 2024 BST.